Latest Articles

This article will explore the role of the immune system and immune evasion in cancer and will discuss how the immune system can be exploited therapeutically and the recent advances in cancer immunotherapy.

A diverse array of biological medicines are now used to prevent and treat a wide range of illnesses. This article will discuss the development of cell lines in biopharma and will touch on key considerations, such as future manufacturability.

Host cell proteins can prove problematic for the development of novel biopharmaceuticals. This article will highlight some of the latest advances in host cell analysis strategies and how they are being implemented.

Drew Burch discusses how next-gen mRNA technology is one of the most valuable tools to combat and control disease outbreaks and why continued investment in this field is crucial for maintaining our pandemic preparedness.

Bayesian statistics has emerged as a powerful methodology for making decisions from data in the applied sciences. Bayesian brings a new way of thinking to statistics, in how it deals with probability, uncertainty and drawing inferences from an analysis.

The gene therapy landscape is dynamic and constantly shifting. In this article, we will review major advances in disease modification for illnesses that presently still lack effective treatments, as well as some challenges and approaches to overcome them.

Though the progress of the biotech and pharma industries is nothing short of commendable, there's a high cost associated with it – its environmental impact.

In this op-ed, Professor Michael S. Kinch argues that the only way we can the COVID-19 pandemic is "to mandate that all individuals are not merely vaccinated but remain up to date with boosters."

Biopharmaceuticals require careful analysis during research, development and manufacturing. In this article, we highlight some of the analytical techniques employed in biopharmaceutical analysis, and how the field is evolving to meet new challenges.

Digitalization underpins the biopharma industry’s endeavors to keep up with innovation and get life-changing therapeutics into the hands of patients as quickly as possible. This article explores how a digital backbone can help to realize the full potential of data and generate meaningful insights.